164 related articles for article (PubMed ID: 16717166)
1. The value of BNP testing.
Hlatky M; Heidenreich P
Arch Intern Med; 2006 May; 166(10):1063-4. PubMed ID: 16717166
[No Abstract] [Full Text] [Related]
2. Questions regarding BNP assays.
Schwam E
Ann Emerg Med; 2006 Feb; 47(2):213-4; author reply 214. PubMed ID: 16431242
[No Abstract] [Full Text] [Related]
3. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
[TBL] [Abstract][Full Text] [Related]
4. Are BNP plasma levels useful in heart failure diagnosis each time? A dyspneic patient with anasarca.
Parrinello G; Torres D; Paterna S; Trapanese C; Pomilla M; Lupo U; Licata G
Am J Emerg Med; 2011 Feb; 29(2):239.e5-239.e10. PubMed ID: 20627214
[No Abstract] [Full Text] [Related]
5. [Clinical applications of brain natriuretic peptide testing].
Scardovi AB; ; ; ; ;
Ital Heart J Suppl; 2004 May; 5(5):343-56. PubMed ID: 15182061
[TBL] [Abstract][Full Text] [Related]
6. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
Morello AM; Januzzi JL
Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
[TBL] [Abstract][Full Text] [Related]
7. [Brain-natriuretic-peptide (BNP) for improvement of the diagnostic determination in a conserving emergency room].
Post F; Peetz D; Knoess P; Rupprecht HJ
Z Kardiol; 2004; 93 Suppl 4():IV31-5. PubMed ID: 15085364
[TBL] [Abstract][Full Text] [Related]
8. NTproBNP--a role to play.
Obel IW
S Afr Med J; 2006 Apr; 96(4):256. PubMed ID: 16670781
[No Abstract] [Full Text] [Related]
9. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
Baggish AL; van Kimmenade RR; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide - a biomarker for all seasons?
Mark DB; Felker GM
N Engl J Med; 2004 Feb; 350(7):718-20. PubMed ID: 14960748
[No Abstract] [Full Text] [Related]
11. [The circulating NTproBNP level, a new biomarker for the diagnosis of heart failure in patients with acute shortness of breath].
Bayés-Genís A
Rev Esp Cardiol; 2005 Oct; 58(10):1142-4. PubMed ID: 16238980
[No Abstract] [Full Text] [Related]
12. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure.
van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL
Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029
[TBL] [Abstract][Full Text] [Related]
13. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
[TBL] [Abstract][Full Text] [Related]
14. Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT.
Kevin Rogers R; Stehlik J; Stoddard GJ; Greene T; Collins SP; Peacock WF; Maisel AD; Clopton P; Michaels AD
Eur J Heart Fail; 2009 Nov; 11(11):1043-9. PubMed ID: 19812054
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
[TBL] [Abstract][Full Text] [Related]
16. [Natriuretic peptides in heart failure].
Hildebrandt P
Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2009. PubMed ID: 12934116
[No Abstract] [Full Text] [Related]
17. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
[TBL] [Abstract][Full Text] [Related]
18. Brain natriuretic peptide in heart failure.
Aronow WS
J Am Geriatr Soc; 2006 Feb; 54(2):368-9; author reply 369. PubMed ID: 16460396
[No Abstract] [Full Text] [Related]
19. Circulating natriuretic peptide levels in acute heart failure.
Maisel A
Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
[TBL] [Abstract][Full Text] [Related]
20. Alveolar membrane conductance decreases as BNP increases during exercise in heart failure. Rationale for BNP in the evaluation of dyspnea.
Cattadori G; Wasserman K; Meloni C; Mustaq S; Contini M; Apostolo A; Andreini D; Magrì D; Sciomer S; Veglia F; Berna G; Introcaso G; Palermo P; Fiorentini C; Agostoni P
J Card Fail; 2009 Mar; 15(2):136-44. PubMed ID: 19254673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
